Hemoptysis is the expectoration (coughing up) of blood or blood-streaked sputum originating from the lower respiratory tract — specifically from the bronchi, bronchioles, or lung parenchyma. It is clinically distinguished from hematemesis (vomiting of blood from the GI tract) and pseudohemoptysis (blood originating from the nasopharynx or oropharynx that is expectorated but not truly coughed up from the lungs). Hemoptysis ranges in severity from blood-streaked sputum (most common, often benign) to massive hemoptysis, classically defined as ≥200-600 mL of blood in 24 hours or any volume sufficient to cause airway obstruction or hemodynamic compromise — a life-threatening emergency. The vast majority of bleeding (approximately 90%) originates from the bronchial circulation (systemic arterial pressure) rather than the pulmonary circulation, which explains the potential for rapid exsanguination. Major etiologic categories include infectious (bronchitis, bronchiectasis, tuberculosis, lung abscess, aspergilloma), neoplastic (primary or metastatic lung malignancy), cardiovascular (pulmonary embolism, mitral stenosis), autoimmune/vasculitic (granulomatosis with polyangiitis, Goodpasture syndrome, microscopic polyangiitis), and iatrogenic (post-bronchoscopy, anticoagulation). In the inpatient and OTL/pulmonology setting, hemoptysis is a CC under MS-DRG grouping when coded as R04.2, making documentation specificity important for accurate DRG capture.
“Spitting,” “expectorating” — from the verb “to spit”
Literally: “spitting of blood” — a precise and elegant descriptor of the clinical act. The root ptysis also appears in hemoptoe (an older synonym), ptysis (spitting in general), and relates to the Greek concept of productive expectoration. The term entered medical English in the early 18th century via Latin from Greek, though descriptions of the symptom date to the Hippocratic corpus. The root haima is one of the most productive in medical terminology, also yielding hematoma, hematuria, hematopoiesis, hemostasis, and hemorrhage.
🔀 ALIASES / ALTERNATE TERMS
Term
Context
Blood-tinged sputum
Mild hemoptysis; streaking without frank blood
Massive hemoptysis
≥200-600 mL/24 hr or airway-threatening — life-threatening emergency
Submassive hemoptysis
Clinically significant but below massive threshold
Hemoptoe
Archaic synonym (Greek/Latin medical texts)
Pulmonary hemorrhage
Broader term; includes intra-alveolar bleeding not always expectorated
Hemoptysis(use when hemoptysis is the presenting symptom and no definitive underlying etiology has been established; a CC under MS-DRG grouping; do not code R04.2 if the underlying cause is known and documented — code the cause instead per ICD-10-CM guidelines)
Bronchoscopy, rigid or flexible, with or without fluoroscopic guidance; diagnostic, with cell washing, when performed (initial diagnostic bronchoscopy for hemoptysis workup)
Bronchoscopy, flexible; with balloon occlusion, with or without assessment of lung compliance, unilateral (balloon tamponade of actively bleeding bronchus — emergent hemoptysis control)
Bronchoscopy, flexible; with destruction of tumor or relief of stenosis by any method other than excision (endobronchial electrocautery / APC for tumor-related hemoptysis)
Vascular embolization or occlusion, inclusive of all radiological supervision and interpretation, intraprocedural roadmapping, and imaging guidance necessary to complete the intervention; for tumors, organ ischemia, or infarction (bronchial artery embolization for massive hemoptysis)
Increased procedural services — complex, prolonged bronchoscopy for massive hemoptysis
⚠️ Coding Note: Per ICD-10-CM guidelines, R04.2 (hemoptysis) is a symptom code and should not be coded when the underlying etiology is known and documented — code the cause (e.g., J47.1 for bronchiectasis with exacerbation, A15.0 for TB, C34.xx for lung malignancy). R04.2 is appropriate as the principal diagnosis when the hemoptysis is the reason for admission and workup has not yet identified a definitive cause by the time of coding. It functions as a CC under MS-DRG, making it valuable when it legitimately stands alone. For neoplastic hemoptysis, always assign the malignancy code to the highest level of specificity with laterality — avoid the unspecified C34.90 when the lobe and side are documented. Bronchial artery embolization (37243) is the IR workhorse for massive hemoptysis and may be the principal procedure on an inpatient claim; confirm documentation includes “embolization” and specifies the bronchial artery as the target vessel. For DAH (diffuse alveolar hemorrhage) in the context of vasculitis, the vasculitis code (M31.30, M31.31, M31.7) drives principal diagnosis selection — R04.2 may be added as an additional code to capture the hemoptysis as a manifestation.
Crystal's MCW Coder Hub